在患有多囊性卵巢综合征的妇女中,用于诱导排卵的淋巴激素
Nienke S Weiss1, Elena B Kostova2, Ben Willem J Mol3
1Gynaecology and Obstetrics, Amstelland Hospital, Amstelveen, Netherlands.
The Cochrane database of systematic reviews
|April 7, 2025
概括
对于对克洛米芬酸盐或莱特醇无反应的PCOS妇女来说,相比继续使用克洛米芬酸盐,淋巴激素 (FSH) 可能会增加活产和临床怀孕,而不会增加多胎妊娠率.
科学领域:
- 生殖内分泌学和不孕不育问题
- 妇科 妇科 妇科 妇科
- 临床试验和证据综合
背景情况:
- 多囊性卵巢综合征 (PCOS) 是无卵性不孕症的常见原因之一.
- 排卵诱导是PCOS相关不孕症的关键治疗方法.
- 卵泡刺激激素 (FSH) 是对女性的第二线治疗PCOS谁不响应口服药物,如克洛米芬酸盐或莱特.
研究的目的:
- 为了比较不同性腺激素在PCOS妇女的排卵诱导中的有效性和安全性.
- 在克洛米芬酸盐或莱特醇失败后,评估淋巴激素作为二线治疗.
主要方法:
- 随机对照试验 (RCT) 的系统审查和元分析.
- 包括的研究比较了复合FSH (rFSH),人更年期性淋巴激素 (HMG),纯化尿液FSH (uFSH) 和高度纯化的FSH (HP-FSH).
- 评估的结果包括活产率,多胎妊娠率,临床妊娠,流产,宫外妊娠和卵巢过度刺激综合征 (OHSS).
主要成果:
- 再组合FSH (rFSH) 与尿源性淋巴激素 (低确定性证据) 相比,活产,多胎妊娠或临床妊娠率几乎没有差异.
- 人类绝经性淋巴激素 (HMG) 与纯化尿液FSH (uFSH) 相比,由于证据确定性非常低,大多数结果的结果不确定.
- 与继续使用克洛米芬酸盐相比,淋巴激素 (FSH) 可能会增加活产和临床怀孕,并可能增加流产率 (中等确定性证据).
结论:
- 淋巴激素,特别是FSH,可能比持续使用克洛米芬酸盐更有效,在初始治疗失败的PCOS妇女中实现活产.
- 比较不同类型的淋巴激素 (rFSH,HMG,uFSH) 的证据确定性低至非常低,因此很难得出明确的结论.
- 需要进一步进行高质量的RCT,以澄清PCOS排卵诱导中的各种淋巴激素制剂的比较有效性和安全性.
相关概念视频
Ovarian Cycle
1.1K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.1K
Hormonal Control of the Ovarian Cycle
439
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
439
Infertility in Females
288
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
288
Oogenesis
63.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.5K
Hormonal Regulation of the Menstrual Cycle
315
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
315
Folliculogenesis
653
Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...
653


